In 2023, the FDA published a report on adverse events associated with the use of mifepristone among consumers. ANSIRH researchers reviewed the report data and found that medication abortion is still very safe and effective.
As of 2022, over 5.9 million US women have used medication abortion with mifepristone and misoprostol since mifepristone was first approved by the US Food and Drug Administration (FDA) in 2000.
An updated review of the data shows that medication abortion continues to be very safe. In fact, it is safer than continuing a pregnancy to term or using other common medications administered in outpatient settings, such as penicillin, Viagra, or Tylenol.
Download ANSIRH’s Analysis of Medication Abortion Risk and the FDA report “Mifepristone US Post-Marketing Adverse Events Summary through 12/31/2022".